|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/185 | |||
| A61K 31/352 | |||
| A61P 25/16 | |||
| A61P 25/28 | |||
| A61P 25/00 | |||
| A61P 9/10 |
| (11) | Patento numeris | 2726069 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12731151.2 |
| Europos patento paraiškos padavimo data | 2012-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2012/051540 |
| Data | 2012-06-29 |
| (87) | Numeris | WO 2013/005017 |
| Data | 2013-01-10 |
| (30) | Numeris | Data | Šalis |
| 201111261 | 2011-07-01 | GB |
| (72) |
IUVONE, Teresa, IT
DI MARZO, Vincenzo, IT
GUY, Geoffrey, GB
WRIGHT, Stephen, GB
STOTT, Colin, GB
|
| (73) |
GW Pharma Limited,
Sovereign House, Histon Cambridge CB24 9BZ,
GB
|
| (54) | CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS |
| CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS |